NDC 36800-836

Mixed Berry Sore Throat Lozenges

Benzocaine

Mixed Berry Sore Throat Lozenges is a Oral Lozenge in the Human Otc Drug category. It is labeled and distributed by Topco Associates. The primary component is Benzocaine; Dextromethorphan Hydrobromide.

Product ID36800-836_7a00c771-9232-e877-e053-2a91aa0ac96e
NDC36800-836
Product TypeHuman Otc Drug
Proprietary NameMixed Berry Sore Throat Lozenges
Generic NameBenzocaine
Dosage FormLozenge
Route of AdministrationORAL
Marketing Start Date2018-08-03
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart356
Labeler NameTopco Associates
Substance NameBENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE
Active Ingredient Strength8 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 36800-836-18

18 LOZENGE in 1 BLISTER PACK (36800-836-18)
Marketing Start Date2018-08-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36800-836-18 [36800083618]

Mixed Berry Sore Throat Lozenges LOZENGE
Marketing CategoryOTC monograph not final
Application Numberpart356
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-08-03

Drug Details

Active Ingredients

IngredientStrength
BENZOCAINE7.5 mg/1

OpenFDA Data

SPL SET ID:7a00c771-9231-e877-e053-2a91aa0ac96e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1039251
  • UPC Code
  • 0036800418400
  • NDC Crossover Matching brand name "Mixed Berry Sore Throat Lozenges" or generic name "Benzocaine"

    NDCBrand NameGeneric Name
    36800-836Mixed Berry Sore Throat LozengesMixed Berry Sore Throat Lozenges
    0283-0220HurriCaineBenzocaine
    0283-0293HurriCaineBenzocaine
    0283-0520HurriCaineBenzocaine
    0283-0569HurriCaineBenzocaine
    0283-0679HurriCaineBenzocaine
    0283-0871HurriCaineBENZOCAINE
    0283-0886HurriCaineBenzocaine
    0283-0914HurriCaineBenzocaine
    0283-0920HurriCaineBenzocaine
    0283-0998HurriCaineBenzocaine
    0283-1016HurriCaineBENZOCAINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.